March, 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Sarah Scagliarini: Sex disparities in advanced urothelial carcinoma are not a trend but a real gap
Mar 15, 2025, 05:11

Sarah Scagliarini: Sex disparities in advanced urothelial carcinoma are not a trend but a real gap

Sarah Scagliarini, Medical Oncologist at Antonio Cardarelli National Hospital, posted on LinkedIn about recent paper by Lorena Incorvai et al., titled “Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab” published on Scientific Reports.

Authors: Lorena Incorvaia, Sarah Scagliarini, Fernando Sabino Marques Monteiro, Hideki Takeshita, Jose Carlos Tapia, María Natalia Gandur Quiroga, Elaine Lam, Deniz Tural, Lazar Popovic, Saul Campos-Gomez, Paolo Andrea Zucali, Augusto Mota, Cinzia Ortega, Juan Pablo Sade, Mimma Rizzo, Ondřej Fiala, Nuno Vau, Patrizia Giannatempo, Halima Abahssain, Andrea Benedetto Galosi, Giuseppe Badalamenti, Jindrich Kopecky, Aristotelis Bamias, Johannes Landmesser, Jawaher Ansari, Fabio Calabrò, Francesco Massari, Sebastiano Buti, Joaquim Bellmunt, Matteo Santoni

Sarah Scagliarini: Sex disparities in advanced urothelial carcinoma are not a trend but a real gap

“Sex disparities in advanced urothelial carcinoma are not a trend but a real gap!

Thanks to Lorena Incorvaia, Matteo Santoni, Joaquim Bellmunt and all ARON project team for this study born from an international collaboration!

Our data of 1039 patients showed that women with metastatic urothelial carcinoma treated with pembrolizumab had shorter OS than men, with a 13% advantage in the 5-year OS rate for male patients.”